50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
S&P 500   3,647.29 (-0.21%)
DOW   29,134.99 (-0.43%)
QQQ   274.48 (+0.04%)
AAPL   151.76 (+0.66%)
MSFT   236.41 (-0.44%)
META   134.40 (-1.44%)
GOOGL   97.50 (-0.68%)
AMZN   114.41 (-0.64%)
TSLA   282.94 (+2.51%)
NVDA   124.13 (+1.51%)
NIO   17.19 (-2.44%)
BABA   77.87 (-1.32%)
AMD   67.17 (+1.31%)
T   15.73 (+0.38%)
MU   50.58 (+3.48%)
CGC   2.86 (+4.38%)
F   11.91 (-0.67%)
GE   64.47 (+0.19%)
DIS   95.85 (-2.31%)
AMC   7.45 (+9.08%)
PYPL   85.75 (+1.77%)
PFE   44.09 (+0.59%)
NFLX   224.36 (+0.13%)
NYSE:STE

STERIS - STE Stock Forecast, Price & News

$160.72
-3.38 (-2.06%)
(As of 09/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$160.08
$165.90
50-Day Range
$164.10
$225.65
52-Week Range
$160.08
$255.93
Volume
942,082 shs
Average Volume
514,824 shs
Market Capitalization
$16.07 billion
P/E Ratio
43.09
Dividend Yield
1.15%
Price Target
$252.00

STERIS MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
56.8% Upside
$252.00 Price Target
Short Interest
Healthy
1.74% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.10mentions of STERIS in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
14.10%
From $8.51 to $9.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.12 out of 5 stars

Medical Sector

13th out of 1,071 stocks

Surgical Appliances & Supplies Industry

3rd out of 21 stocks

STE stock logo

About STERIS (NYSE:STE) Stock

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Stock News Headlines

126% Average Gains While Stocks Crash
Investors have lost $15 trillion so far, and it's about to get much worse. But Dr. Martin Weiss offers the solution with “Crash Profits Trades.” These could have produced average gains of 126% with NO losing trades, even with stocks tumbling! Click here to discover Crash Profit Trades. pixel
STERIS (NYSE:STE) Downgraded by Needham & Company LLC to "Hold"
126% Average Gains While Stocks Crash
Investors have lost $15 trillion so far, and it's about to get much worse. But Dr. Martin Weiss offers the solution with “Crash Profits Trades.” These could have produced average gains of 126% with NO losing trades, even with stocks tumbling! Click here to discover Crash Profit Trades. pixel
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Company Calendar

Last Earnings
11/02/2021
Ex-Dividend for 9/23 Dividend
9/06/2022
Dividend Payable
9/23/2022
Today
9/27/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
85915210
Employees
16,422
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$252.00
High Stock Price Forecast
$275.00
Low Stock Price Forecast
$237.00
Forecasted Upside/Downside
+56.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$243.89 million
Pretax Margin
10.02%

Debt

Sales & Book Value

Annual Sales
$4.59 billion
Cash Flow
$13.42 per share
Book Value
$65.36 per share

Miscellaneous

Free Float
99,065,000
Market Cap
$16.07 billion
Optionable
Optionable
Beta
0.75

Social Links


Key Executives

  • Mr. Daniel A. CarestioMr. Daniel A. Carestio (Age 49)
    Pres, CEO & Director
    Comp: $1.63M
  • Mr. Michael J. TokichMr. Michael J. Tokich (Age 53)
    Sr. VP & CFO
    Comp: $1.03M
  • Mr. John Adam ZangerleMr. John Adam Zangerle (Age 55)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $800.03k
  • Mr. Walter M. Rosebrough Jr.Mr. Walter M. Rosebrough Jr. (Age 68)
    CEO Emeritus & Sr. Advisor
    Comp: $1.16M
  • Mr. Cary L. Majors (Age 47)
    Sr. VP of Americas Commercial Operations
    Comp: $734.37k
  • Mr. Andrew Xilas (Age 57)
    Sr. VP & GM of Dental
    Comp: $1.44M
  • Ms. Karen L. BurtonMs. Karen L. Burton (Age 54)
    Chief Accounting Officer, VP & Controller
  • Julie Winter
    VP of Investor Relations & Corp. Communications
  • Ms. Mary Clare Fraser (Age 52)
    VP & Chief HR Officer
  • Ms. Julia K. Madsen (Age 57)
    Sr. VP of Life Sciences













STE Stock - Frequently Asked Questions

Should I buy or sell STERIS stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STE shares.
View STE analyst ratings
or view top-rated stocks.

What is STERIS's stock price forecast for 2022?

6 equities research analysts have issued 1 year target prices for STERIS's stock. Their STE share price forecasts range from $237.00 to $275.00. On average, they predict the company's stock price to reach $252.00 in the next twelve months. This suggests a possible upside of 56.8% from the stock's current price.
View analysts price targets for STE
or view top-rated stocks among Wall Street analysts.

How have STE shares performed in 2022?

STERIS's stock was trading at $243.41 at the beginning of the year. Since then, STE stock has decreased by 34.0% and is now trading at $160.72.
View the best growth stocks for 2022 here
.

Are investors shorting STERIS?

STERIS saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 1,890,000 shares, an increase of 31.3% from the July 31st total of 1,440,000 shares. Based on an average daily volume of 478,100 shares, the days-to-cover ratio is currently 4.0 days. Currently, 1.9% of the shares of the company are sold short.
View STERIS's Short Interest
.

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our STE earnings forecast
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) announced its earnings results on Tuesday, November, 2nd. The medical equipment provider reported $1.99 EPS for the quarter, beating analysts' consensus estimates of $1.82 by $0.17. The medical equipment provider had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.16 billion. STERIS had a trailing twelve-month return on equity of 12.40% and a net margin of 7.90%. During the same period last year, the company posted $1.48 earnings per share.
Read the conference call transcript
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Thursday, July 28th. Shareholders of record on Wednesday, September 7th will be paid a dividend of $0.47 per share on Friday, September 23rd. This represents a $1.88 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Tuesday, September 6th. This is a boost from the stock's previous quarterly dividend of $0.43.
Read our dividend analysis for STE
.

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $1.88 per share and currently has a dividend yield of 1.15%. The company has been increasing its dividend for 16 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 50.40%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STE will have a dividend payout ratio of 19.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STE.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY 2023 earnings guidance on Tuesday, August, 9th. The company provided EPS guidance of $8.40-$8.60 for the period, compared to the consensus estimate of $8.70. The company issued revenue guidance of $5.00 billion-$5.00 billion, compared to the consensus revenue estimate of $5.12 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by many different retail and institutional investors. Top institutional investors include WCM Investment Management LLC (6.10%), Massachusetts Financial Services Co. MA (4.60%), State Street Corp (4.24%), Price T Rowe Associates Inc. MD (2.39%), Pictet Asset Management SA (1.69%) and Northern Trust Corp (1.31%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends
.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $160.72.

How much money does STERIS make?

STERIS (NYSE:STE) has a market capitalization of $16.07 billion and generates $4.59 billion in revenue each year. The medical equipment provider earns $243.89 million in net income (profit) each year or $3.73 on an earnings per share basis.

How many employees does STERIS have?

The company employs 16,422 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (531) 232-2000, via email at julie_winter@steris.com, or via fax at 440-639-4457.

This page (NYSE:STE) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.